Policy No: 7710.08.04 - PN.13 Policy No: 7710.08.04 - Medication Policy: Suboxone (buprenorphine-naloxone) Policy No: 7710.09.PYXIS - PYXIS MEDSTATION – Authorized Privilege for Access to System Policy No: CLI.003 STANDARD OPERERATING PROCEDURE- Policy No: CLI.004 - STANDARD OPERERATING PROCEDURE Methadone Maintenance: Prescribing, Dispensing and Administration Policy No: PN.01 - ADULT INJECTABLE MEDICATION ADMINISTRATION REFERENCE Policy No: PN.02 - STANDARD ADULT IVPB ADMIXTURES Policy No: PN.03 - STANDARD CONCENTRATION AND ADMIXTURE POLICY OF IV DRIPS (ADULT) Policy No: PN.03b - Plum A+ Drug Library Report Policy No: PN.03c - HOSPIRA® MEDNET PCA Settings Policy No: PN.04 - Protocol for Sedation and Analgesia of Mechanically Ventilated Patients Policy No: PN.05a - MEDICATION ADMINISTRATION STANDARDIZATION TIMES Policy No: PN.05b - 2016 Look-Alike/Sound-Alike Medications Policy No: PN.05c - 2016 HRMC high-risk or high-alert medications Policy No: PN.06a - Therapeutic Substitutions Policy No: PN.06b - Clinical Policy Medication Orders - Stop Order Policy Policy No: PN.06c - GLUCOSE (Hypo/Hyperglycemia) PROTOCOL Policy No: PN.07a - Patient’s Own Medication Policy No: PN.07b - MEDICATION PREPARATION, HANDLING, and STORAGE Policy No: PN.08a - AMINOGLYCOSIDE (GENTAMICIN, TOBRAMYCIN, AMIKACIN) & VANCOMYCIN PEAK, TROUGH, AND RANDOM CONCENTRATION DETERMINATION Policy No: PN.08b - THERAPEUTIC MEDICATION MONITORING DRAW TIMES Policy No: PN.09a - HRMC HIV Post-Exposure Prophylaxis (PEP) guidelines* Policy No: PN.09b - HRMC Antidote Reference Policy No: PN.09c - HRMC Electrolyte Management Reference Policy No: PN.09d - Lovenox (enoxaparin) dosing guidelines Policy No: PN.09e - NARCOTIC CONVERSION CHART Policy No: PN.09f - Antimicrobial Prophylaxis for Elective Surgical Procedures, ADULT Policy No: PN.10 - HRMC Formulary Policy No: PN.11 - Electronic Medication Administration - Overall Process (eMAR) Policy No: PN.12 - Obtaining, removing, Returning, and Wasting of Controlled Substances Policy No: PN.13 - Monitoring Effects of Medication on Patients
Policy No: 7710.08.04 - PN.13 Policy No: 7710.08.04 - Medication Policy: Suboxone (buprenorphine-naloxone) Policy No: 7710.09.PYXIS - PYXIS MEDSTATION – Authorized Privilege for Access to System Policy No: CLI.003 STANDARD OPERERATING PROCEDURE- Policy No: CLI.004 - STANDARD OPERERATING PROCEDURE Methadone Maintenance: Prescribing, Dispensing and Administration Policy No: PN.01 - ADULT INJECTABLE MEDICATION ADMINISTRATION REFERENCE Policy No: PN.02 - STANDARD ADULT IVPB ADMIXTURES Policy No: PN.03 - STANDARD CONCENTRATION AND ADMIXTURE POLICY OF IV DRIPS (ADULT) Policy No: PN.03b - Plum A+ Drug Library Report Policy No: PN.03c - HOSPIRA® MEDNET PCA Settings Policy No: PN.04 - Protocol for Sedation and Analgesia of Mechanically Ventilated Patients Policy No: PN.05a - MEDICATION ADMINISTRATION STANDARDIZATION TIMES Policy No: PN.05b - 2016 Look-Alike/Sound-Alike Medications Policy No: PN.05c - 2016 HRMC high-risk or high-alert medications Policy No: PN.06a - Therapeutic Substitutions Policy No: PN.06b - Clinical Policy Medication Orders - Stop Order Policy Policy No: PN.06c - GLUCOSE (Hypo/Hyperglycemia) PROTOCOL Policy No: PN.07a - Patient’s Own Medication Policy No: PN.07b - MEDICATION PREPARATION, HANDLING, and STORAGE Policy No: PN.08a - AMINOGLYCOSIDE (GENTAMICIN, TOBRAMYCIN, AMIKACIN) & VANCOMYCIN PEAK, TROUGH, AND RANDOM CONCENTRATION DETERMINATION Policy No: PN.08b - THERAPEUTIC MEDICATION MONITORING DRAW TIMES Policy No: PN.09a - HRMC HIV Post-Exposure Prophylaxis (PEP) guidelines* Policy No: PN.09b - HRMC Antidote Reference Policy No: PN.09c - HRMC Electrolyte Management Reference Policy No: PN.09d - Lovenox (enoxaparin) dosing guidelines Policy No: PN.09e - NARCOTIC CONVERSION CHART Policy No: PN.09f - Antimicrobial Prophylaxis for Elective Surgical Procedures, ADULT Policy No: PN.10 - HRMC Formulary Policy No: PN.11 - Electronic Medication Administration - Overall Process (eMAR) Policy No: PN.12 - Obtaining, removing, Returning, and Wasting of Controlled Substances Policy No: PN.13 - Monitoring Effects of Medication on Patients
